Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Norepinephrine in Vasoplegic Shock (VANCSIII)
NCT03483753Phase 3Withdrawn
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2019
- Primary completion
- Oct 2023
- Modality
- Peptides
01
Overview
A Phase 3 trial of vasopressin in vasoplegic shock, sponsored by Universidade de São Paulo. Planned start Jan 2019; status: withdrawn.
02
Drugs
vasopressin
03
Conditions
vasoplegic shock
Beyond the preview
Go deeper on NCT03483753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03483753.